Relay Therapeutics saw the highest growth of 1.99% in patent filings and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.99% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Relay Therapeutics’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Relay Therapeutics has been focused on protecting inventions in European Patent Office(EPO) with four publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings with nearly 22% of filings. The European Patent Office(EPO), United States(US), World Intellectual Property Organization(WIPO), and Argentina(AR) patent Office are among the top ten patent offices where Relay Therapeutics is filings its patents..
Roche could be the strongest competitor for Relay Therapeutics
Patents related to rare diseases and healthtech lead Relay Therapeutics's portfolio
Relay Therapeutics has the highest number of patents in rare diseases followed by, healthtech and connected patient. For rare diseases, nearly 100% of patents were filed and no patents were granted in Q2 2024.
Breast cancer related patents lead Relay Therapeutics portfolio followed by lung cancer, and colorectal tumor
Relay Therapeutics has highest number of patents in breast cancer followed by lung cancer, colorectal tumor, liver cancer, and ovarian cancer.
For comprehensive analysis of Relay Therapeutics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
